Development Drug Trials FDA Approval Licensing 
XTalks
APRIL 26, 2021
After years of disappointing malaria vaccine trials, a malaria shot developed by researchers at the Jenner Institute at the University of Oxford has demonstrated an unprecedentedly high efficacy of 77 percent, and may be the magic bullet the world has been waiting for against the deadly disease. Malaria Vaccine Phase II Trial.
Delveinsight
AUGUST 12, 2021
LQTT has a portfolio of in-licensed compounds from Sanofi that prohibit serum/glucocorticoid-regulated kinase 1, or SGK1. Under the agreement, struck in April 2017, Takeda, which eyes GI as one of its core areas, handed over USD 10 million upfront for the global rights to develop and sell FIN-524, a microbiome IBD treatment.
Drug Discovery World
MARCH 7, 2023
She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialisation, and at Georgetown Law School as an adjunct professor.
Expert insights. Personalized for you.
105 
Let's personalize your content